C
Cathoholic
Guest
FDA grants emergency authorisation to chloroquine for COVID-19
March 30, 2020 PM Live. Lucy Parsons
The US Food and Drug Administration (FDA) has approved the use of the decades old anti-malaria drugs hydroxychloroquine and chloroquine after preliminary data showed they had efficacy against COVID-19, the disease caused by the novel coronavirus.
The emergency authorisation comes on the back of results from a small study in France, in which four out of five COVID-19 patients who were treated with chloroquine had ‘favourable’ outcomes.
The results also demonstrated that 65 of the 80 patients receiving chloroquine treatment improved and were discharged from hospital in an average of less than five days.
This data supports earlier preliminary results from a small study of hydroxychloroquine in combination with the antibiotic azithromycin, and as a monotherapy.
Although the drug was effective on its own, when added to the antibiotic azithromycin, hydroxychloroquine was found to produce a superior response, by a significant margin.
The drug has already been touted as a potential treatment by President Donald Trump, who implied that the drug was approved for use in COVID-19 on 20 March. . . .
Remember. “FDA approval” is for ADVERTIZING (and other aspects). Not necessarily for physician USAGE in patients.
Physicians successfully use medications “off-label” for many things.
It also helps in legal issues.
The difference between this regimen and nothing
is so stark so far,
that many people think randomizing them to “placebo” in a prospective double-blind study at this point would be unethical.
Last edited: